Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982 May;36(2):691-5.
doi: 10.1128/iai.36.2.691-695.1982.

Virus-infected colostral cell cytokine stimulation of human leukocyte natural killer cytotoxicity

Free PMC article

Virus-infected colostral cell cytokine stimulation of human leukocyte natural killer cytotoxicity

S Kohl et al. Infect Immun. 1982 May.
Free PMC article

Abstract

Natural killer cytotoxicity is an important antiviral defense mechanism. Human peripheral blood mononuclear cells cultured with herpes simplex virus (HSV)-infected cells produced a cytokine. This substance stimulated adult natural killer cytotoxicity from 53.0 +/- 10.5% to 79.8% (P less than 0.01) against HSV-infected target cells. These data resulted in a calculated cytokine-dependent cellular cytotoxicity (CDCC) value of 65.8%. Cytokine production was not stimulated by uninfected cells and was independent of the presence or absence of antibodies to HSV in sera of donors and mononuclear cells. Cells from human colostrum also produced an HSV-stimulated cytokine which mediated CDCC by using both adult (19.8 +/- 3.9%) and neonatal (18.6 +/- 3.4%) mononuclear effectors cells. Colostral cell cytokine production was also independent of donor HSV serology. Not all colostral cultures produced the cytokine, and in general colostrum-stimulated CDCC was lower than peripheral blood leukocyte-stimulated CDCC. Colostral cell cytokine stimulation of neonatal natural killer cytotoxicity may account in part for the increased nonspecific resistance of breast-fed infants to viral infection.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Scand J Immunol. 1974;3(2):157-60 - PubMed
    1. Infect Immun. 1976 Jul;14(1):47-54 - PubMed
    1. Br Med J. 1976 Jul 31;2(6030):274-6 - PubMed
    1. J Immunol. 1977 Mar;118(3):729-35 - PubMed
    1. J Pediatr. 1977 May;90(5):726-9 - PubMed

Publication types

LinkOut - more resources